"A PHARMACEUTICAL COMPOSTION."
Application 1986/DELNP/2005 published 2007-01-19, filed 2005-05-10
A method and composition for mitigating the adverse effects of lnterleukin-2 (IL-2) on a subject is disclosed. The method involves administering an amount of a leukotriene receptor antagonist to a subject exhibiting adverse pharmacological effects due to exogenous IL-2, where the amount administered to the subject is sufficient to decrease the IL-2 induced adverse effects. Also disclosed is an article of manufacturing comprising a composition of the leukotriene receptor antagonist in combination with labeling instructions for treatment. Also disclosed is a method for preparing a pharmaceutical composition.
Applicant
1)BIO MEDICINES, INC.
:1301 MARINA VILLAGE PARKWAY #200, ALAMEDA, CA 94501, USA. U.S.A.
Inventor
1)MORAN STANFORD MARK
International Info
Classification: A61K 31/35
Publication Number: WO 00/12086
Application Date: 1999-08-18
Priority Information
60/098,341 U.S.A. 1998-08-28